Long-term efficacy and tolerance of rituximab for post-transfusional alloimmune haemolytic anaemia in a thalassaemia patient.
Littera
Roberto
R
Arras
Marcella
M
Ledda
Antonio
A
Caocci
Giovanni
G
Tronci
Maria Bonaria
MB
Carcassi
Carlo
C
La Nasa
Giorgio
G
D000328:Adult; D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D000069283:Rituximab; D065227:Transfusion Reaction; D017086:beta-Thalassemia / Q000150:complications*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab